Han-Chuan Wang , Yu-Qi Shi , Bing-Hang Ji, Zhu-Ling-Zhi Kuang, Ce Song, Wen-Zhuo Ming, Yu-Meng Wang, Da-Li Meng
{"title":"泽兰倍半萜类化合物通过DNA-PK/AKT/p53通路诱导AGS细胞G0/G1细胞周期阻滞和凋亡","authors":"Han-Chuan Wang , Yu-Qi Shi , Bing-Hang Ji, Zhu-Ling-Zhi Kuang, Ce Song, Wen-Zhuo Ming, Yu-Meng Wang, Da-Li Meng","doi":"10.1016/j.bioorg.2025.109059","DOIUrl":null,"url":null,"abstract":"<div><div>Ten undescribed sesquiterpenes, including 5 undescribed guaiane-type sesquiterpenes (<strong>1–5</strong>) and 5 undescribed gemmarane-type sesquiterpenes (<strong>6–10</strong>), along with fourteen known analogues (<strong>11–24</strong>) were isolated from the whole plants of <em>Eupatorium chinense</em> L. They structures were determined by interpretation of spectroscopic data (UV, NMR, ECD, HRESIMS, and DP4+). The cytotoxicity of sesquiterpene derivatives (<strong>1–24)</strong> was evaluated against five human cancer cell lines (Hep<img>3B, A549, AGS, MCF-7, and HCT-116). Among these, compound <strong>1</strong> exhibited the most potent cytotoxic activity against the gastric adenocarcinoma AGS cell line, with an IC<sub>50</sub> value of 4.33 μM. Mechanistic studies revealed that compound <strong>1</strong> suppresses the DNA-PK/AKT/p53 signaling pathway in AGS cells. Concomitantly, it upregulates p21 protein expression while downregulating CDK4 and cyclin D protein levels, inducing G<sub>0</sub>/G<sub>1</sub> phase cell cycle arrest. Furthermore, compound <strong>1</strong> promotes apoptosis by increasing Bax expression and decreasing Bcl-2 expression. Collectively, these findings establish compound <strong>1</strong> as a promising lead candidate for the development of novel anti-gastric cancer therapeutics.</div></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"165 ","pages":"Article 109059"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sesquiterpenoids from Eupatorium chinense L. induce G0/G1 cell cycle arrest and apoptosis in AGS cell via DNA-PK/AKT/p53 pathway\",\"authors\":\"Han-Chuan Wang , Yu-Qi Shi , Bing-Hang Ji, Zhu-Ling-Zhi Kuang, Ce Song, Wen-Zhuo Ming, Yu-Meng Wang, Da-Li Meng\",\"doi\":\"10.1016/j.bioorg.2025.109059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Ten undescribed sesquiterpenes, including 5 undescribed guaiane-type sesquiterpenes (<strong>1–5</strong>) and 5 undescribed gemmarane-type sesquiterpenes (<strong>6–10</strong>), along with fourteen known analogues (<strong>11–24</strong>) were isolated from the whole plants of <em>Eupatorium chinense</em> L. They structures were determined by interpretation of spectroscopic data (UV, NMR, ECD, HRESIMS, and DP4+). The cytotoxicity of sesquiterpene derivatives (<strong>1–24)</strong> was evaluated against five human cancer cell lines (Hep<img>3B, A549, AGS, MCF-7, and HCT-116). Among these, compound <strong>1</strong> exhibited the most potent cytotoxic activity against the gastric adenocarcinoma AGS cell line, with an IC<sub>50</sub> value of 4.33 μM. Mechanistic studies revealed that compound <strong>1</strong> suppresses the DNA-PK/AKT/p53 signaling pathway in AGS cells. Concomitantly, it upregulates p21 protein expression while downregulating CDK4 and cyclin D protein levels, inducing G<sub>0</sub>/G<sub>1</sub> phase cell cycle arrest. Furthermore, compound <strong>1</strong> promotes apoptosis by increasing Bax expression and decreasing Bcl-2 expression. Collectively, these findings establish compound <strong>1</strong> as a promising lead candidate for the development of novel anti-gastric cancer therapeutics.</div></div>\",\"PeriodicalId\":257,\"journal\":{\"name\":\"Bioorganic Chemistry\",\"volume\":\"165 \",\"pages\":\"Article 109059\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0045206825009393\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0045206825009393","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Sesquiterpenoids from Eupatorium chinense L. induce G0/G1 cell cycle arrest and apoptosis in AGS cell via DNA-PK/AKT/p53 pathway
Ten undescribed sesquiterpenes, including 5 undescribed guaiane-type sesquiterpenes (1–5) and 5 undescribed gemmarane-type sesquiterpenes (6–10), along with fourteen known analogues (11–24) were isolated from the whole plants of Eupatorium chinense L. They structures were determined by interpretation of spectroscopic data (UV, NMR, ECD, HRESIMS, and DP4+). The cytotoxicity of sesquiterpene derivatives (1–24) was evaluated against five human cancer cell lines (Hep3B, A549, AGS, MCF-7, and HCT-116). Among these, compound 1 exhibited the most potent cytotoxic activity against the gastric adenocarcinoma AGS cell line, with an IC50 value of 4.33 μM. Mechanistic studies revealed that compound 1 suppresses the DNA-PK/AKT/p53 signaling pathway in AGS cells. Concomitantly, it upregulates p21 protein expression while downregulating CDK4 and cyclin D protein levels, inducing G0/G1 phase cell cycle arrest. Furthermore, compound 1 promotes apoptosis by increasing Bax expression and decreasing Bcl-2 expression. Collectively, these findings establish compound 1 as a promising lead candidate for the development of novel anti-gastric cancer therapeutics.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.